Instant International
Written by: Hong Yilin
2021-05-08 09:34
The last update date: 2021-05-08 09:34
The World Health Organization (WHO) said on May 7 that it has requested Sinovac Biotech to provide more information on the new coronavirus pneumonia (COVID-19) vaccine it has developed, and hopes to receive the data soon to make a decision. .
The WHO announced the approval of the emergency use of the Sinopharm vaccine on the same day. It also said that the Kexing vaccine had been reviewed on the 5th, or a decision would be made next week.
Want to know the lives of people in other countries during the epidemic? Please click to enlarge to watch:
New Coronary Pneumonia｜WHO Approves Sinopharm Vaccine for Emergency Use
WHO experts review Kexing and Sinopharm vaccines have low confidence in side effects data
Vaccines in China | Why is the WHO's approval for emergency use so important?
Arnaud Didierlaurent, Chairman of the WHO Technical Advisory Group, said at the press conference: "We have started to review the report from Coching. We have actually asked the manufacturer to provide more information, and we hope to receive it as soon as possible. To (the information) to make a decision.”
New crown vaccine vaccine new crown pneumonia global epidemic WHO China Kexing
